Logo image of 1JNJ.MI

JOHNSON & JOHNSON (1JNJ.MI) Stock Fundamental Analysis

Europe - Euronext Milan - BIT:1JNJ - US4781601046 - Common Stock

176.08 EUR
+3.32 (+1.92%)
Last: 1/6/2026, 7:00:00 PM
Fundamental Rating

6

1JNJ gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 53 industry peers in the Pharmaceuticals industry. While 1JNJ belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. 1JNJ has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • In the past year 1JNJ was profitable.
  • In the past year 1JNJ had a positive cash flow from operations.
  • Each year in the past 5 years 1JNJ has been profitable.
  • In the past 5 years 1JNJ always reported a positive cash flow from operatings.
1JNJ.MI Yearly Net Income VS EBIT VS OCF VS FCF1JNJ.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

1.2 Ratios

  • The Return On Assets of 1JNJ (13.03%) is better than 81.13% of its industry peers.
  • Looking at the Return On Equity, with a value of 31.69%, 1JNJ is in the better half of the industry, outperforming 75.47% of the companies in the same industry.
  • 1JNJ has a Return On Invested Capital of 14.68%. This is in the better half of the industry: 1JNJ outperforms 73.58% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for 1JNJ is in line with the industry average of 14.02%.
Industry RankSector Rank
ROA 13.03%
ROE 31.69%
ROIC 14.68%
ROA(3y)12.79%
ROA(5y)11.65%
ROE(3y)31.38%
ROE(5y)29.12%
ROIC(3y)15.41%
ROIC(5y)14.48%
1JNJ.MI Yearly ROA, ROE, ROIC1JNJ.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

1.3 Margins

  • 1JNJ's Profit Margin of 27.26% is amongst the best of the industry. 1JNJ outperforms 86.79% of its industry peers.
  • In the last couple of years the Profit Margin of 1JNJ has declined.
  • 1JNJ's Operating Margin of 27.00% is fine compared to the rest of the industry. 1JNJ outperforms 73.58% of its industry peers.
  • 1JNJ's Operating Margin has improved in the last couple of years.
  • 1JNJ's Gross Margin of 68.14% is in line compared to the rest of the industry. 1JNJ outperforms 47.17% of its industry peers.
  • In the last couple of years the Gross Margin of 1JNJ has remained more or less at the same level.
Industry RankSector Rank
OM 27%
PM (TTM) 27.26%
GM 68.14%
OM growth 3Y0.33%
OM growth 5Y3.14%
PM growth 3Y-15.79%
PM growth 5Y-2.98%
GM growth 3Y-0.56%
GM growth 5Y0.76%
1JNJ.MI Yearly Profit, Operating, Gross Margins1JNJ.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

6

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so 1JNJ is still creating some value.
  • 1JNJ has about the same amout of shares outstanding than it did 1 year ago.
  • 1JNJ has less shares outstanding than it did 5 years ago.
  • 1JNJ has a worse debt/assets ratio than last year.
1JNJ.MI Yearly Shares Outstanding1JNJ.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B
1JNJ.MI Yearly Total Debt VS Total Assets1JNJ.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B

2.2 Solvency

  • An Altman-Z score of 4.75 indicates that 1JNJ is not in any danger for bankruptcy at the moment.
  • 1JNJ's Altman-Z score of 4.75 is fine compared to the rest of the industry. 1JNJ outperforms 67.92% of its industry peers.
  • The Debt to FCF ratio of 1JNJ is 2.34, which is a good value as it means it would take 1JNJ, 2.34 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 2.34, 1JNJ belongs to the top of the industry, outperforming 83.02% of the companies in the same industry.
  • 1JNJ has a Debt/Equity ratio of 0.55. This is a neutral value indicating 1JNJ is somewhat dependend on debt financing.
  • 1JNJ's Debt to Equity ratio of 0.55 is in line compared to the rest of the industry. 1JNJ outperforms 56.60% of its industry peers.
  • Although 1JNJ does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
Industry RankSector Rank
Debt/Equity 0.55
Debt/FCF 2.34
Altman-Z 4.75
ROIC/WACC1.5
WACC9.78%
1JNJ.MI Yearly LT Debt VS Equity VS FCF1JNJ.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.3 Liquidity

  • A Current Ratio of 1.07 indicates that 1JNJ should not have too much problems paying its short term obligations.
  • 1JNJ has a Current ratio of 1.07. This is in the lower half of the industry: 1JNJ underperforms 64.15% of its industry peers.
  • A Quick Ratio of 0.80 indicates that 1JNJ may have some problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 0.80, 1JNJ is in line with its industry, outperforming 41.51% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.07
Quick Ratio 0.8
1JNJ.MI Yearly Current Assets VS Current Liabilites1JNJ.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

4

3. Growth

3.1 Past

  • The Earnings Per Share has been growing slightly by 1.37% over the past year.
  • Measured over the past 5 years, 1JNJ shows a small growth in Earnings Per Share. The EPS has been growing by 2.85% on average per year.
  • Looking at the last year, 1JNJ shows a small growth in Revenue. The Revenue has grown by 5.08% in the last year.
  • 1JNJ shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.60% yearly.
EPS 1Y (TTM)1.37%
EPS 3Y0.64%
EPS 5Y2.85%
EPS Q2Q%15.7%
Revenue 1Y (TTM)5.08%
Revenue growth 3Y4.1%
Revenue growth 5Y1.6%
Sales Q2Q%6.77%

3.2 Future

  • The Earnings Per Share is expected to grow by 7.93% on average over the next years.
  • 1JNJ is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.37% yearly.
EPS Next Y9.85%
EPS Next 2Y8.02%
EPS Next 3Y7.82%
EPS Next 5Y7.93%
Revenue Next Year5.61%
Revenue Next 2Y5.47%
Revenue Next 3Y5.32%
Revenue Next 5Y5.37%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
1JNJ.MI Yearly Revenue VS Estimates1JNJ.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 20B 40B 60B 80B 100B
1JNJ.MI Yearly EPS VS Estimates1JNJ.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5 10 15

4

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 19.76, which indicates a rather expensive current valuation of 1JNJ.
  • Compared to the rest of the industry, the Price/Earnings ratio of 1JNJ is on the same level as its industry peers.
  • 1JNJ is valuated rather cheaply when we compare the Price/Earnings ratio to 27.33, which is the current average of the S&P500 Index.
  • With a Price/Forward Earnings ratio of 17.60, 1JNJ is valued on the expensive side.
  • 1JNJ's Price/Forward Earnings ratio is in line with the industry average.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 24.12, 1JNJ is valued a bit cheaper.
Industry RankSector Rank
PE 19.76
Fwd PE 17.6
1JNJ.MI Price Earnings VS Forward Price Earnings1JNJ.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

  • The rest of the industry has a similar Enterprise Value to EBITDA ratio as 1JNJ.
  • Based on the Price/Free Cash Flow ratio, 1JNJ is valued a bit cheaper than 60.38% of the companies in the same industry.
Industry RankSector Rank
P/FCF 25.23
EV/EBITDA 15.72
1JNJ.MI Per share data1JNJ.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • The decent profitability rating of 1JNJ may justify a higher PE ratio.
PEG (NY)2.01
PEG (5Y)6.93
EPS Next 2Y8.02%
EPS Next 3Y7.82%

5

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 2.53%, 1JNJ has a reasonable but not impressive dividend return.
  • 1JNJ's Dividend Yield is a higher than the industry average which is at 1.72.
  • Compared to an average S&P500 Dividend Yield of 1.91, 1JNJ pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 2.53%

5.2 History

  • On average, the dividend of 1JNJ grows each year by 9.24%, which is quite nice.
Dividend Growth(5Y)9.24%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • 48.70% of the earnings are spent on dividend by 1JNJ. This is a bit on the high side, but may be sustainable.
  • 1JNJ's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP48.7%
EPS Next 2Y8.02%
EPS Next 3Y7.82%
1JNJ.MI Yearly Income VS Free CF VS Dividend1JNJ.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B
1JNJ.MI Dividend Payout.1JNJ.MI Dividend Payout, showing the Payout Ratio.1JNJ.MI Dividend Payout.PayoutRetained Earnings

JOHNSON & JOHNSON

BIT:1JNJ (1/6/2026, 7:00:00 PM)

176.08

+3.32 (+1.92%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)10-14
Earnings (Next)01-21
Inst Owners75.09%
Inst Owner ChangeN/A
Ins Owners0.03%
Ins Owner ChangeN/A
Market Cap424.23B
Revenue(TTM)92.15B
Net Income(TTM)25.12B
Analysts75
Price Target183.68 (4.32%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.53%
Yearly Dividend4.22
Dividend Growth(5Y)9.24%
DP48.7%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)1.42%
Min EPS beat(2)0.55%
Max EPS beat(2)2.3%
EPS beat(4)4
Avg EPS beat(4)2.37%
Min EPS beat(4)0.55%
Max EPS beat(4)5.96%
EPS beat(8)7
Avg EPS beat(8)2.79%
EPS beat(12)11
Avg EPS beat(12)3.6%
EPS beat(16)14
Avg EPS beat(16)3.08%
Revenue beat(2)2
Avg Revenue beat(2)1.48%
Min Revenue beat(2)0.03%
Max Revenue beat(2)2.92%
Revenue beat(4)3
Avg Revenue beat(4)0.74%
Min Revenue beat(4)-0.55%
Max Revenue beat(4)2.92%
Revenue beat(8)5
Avg Revenue beat(8)0.34%
Revenue beat(12)7
Avg Revenue beat(12)-2.01%
Revenue beat(16)7
Avg Revenue beat(16)-8.34%
PT rev (1m)3.41%
PT rev (3m)17.02%
EPS NQ rev (1m)0.12%
EPS NQ rev (3m)-1.66%
EPS NY rev (1m)0.02%
EPS NY rev (3m)0.05%
Revenue NQ rev (1m)0.03%
Revenue NQ rev (3m)0.23%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.36%
Valuation
Industry RankSector Rank
PE 19.76
Fwd PE 17.6
P/S 5.37
P/FCF 25.23
P/OCF 20.43
P/B 6.24
P/tB N/A
EV/EBITDA 15.72
EPS(TTM)8.91
EY5.06%
EPS(NY)10
Fwd EY5.68%
FCF(TTM)6.98
FCFY3.96%
OCF(TTM)8.62
OCFY4.9%
SpS32.82
BVpS28.23
TBVpS-6.24
PEG (NY)2.01
PEG (5Y)6.93
Graham Number75.24
Profitability
Industry RankSector Rank
ROA 13.03%
ROE 31.69%
ROCE 17.53%
ROIC 14.68%
ROICexc 16.82%
ROICexgc 69.32%
OM 27%
PM (TTM) 27.26%
GM 68.14%
FCFM 21.27%
ROA(3y)12.79%
ROA(5y)11.65%
ROE(3y)31.38%
ROE(5y)29.12%
ROIC(3y)15.41%
ROIC(5y)14.48%
ROICexc(3y)18.76%
ROICexc(5y)17.88%
ROICexgc(3y)74.12%
ROICexgc(5y)78.04%
ROCE(3y)18.6%
ROCE(5y)17.28%
ROICexgc growth 3Y1.2%
ROICexgc growth 5Y-0.66%
ROICexc growth 3Y3.58%
ROICexc growth 5Y3.41%
OM growth 3Y0.33%
OM growth 5Y3.14%
PM growth 3Y-15.79%
PM growth 5Y-2.98%
GM growth 3Y-0.56%
GM growth 5Y0.76%
F-Score5
Asset Turnover0.48
Health
Industry RankSector Rank
Debt/Equity 0.55
Debt/FCF 2.34
Debt/EBITDA 1.36
Cap/Depr 62.36%
Cap/Sales 5%
Interest Coverage 250
Cash Conversion 75.02%
Profit Quality 78.02%
Current Ratio 1.07
Quick Ratio 0.8
Altman-Z 4.75
F-Score5
WACC9.78%
ROIC/WACC1.5
Cap/Depr(3y)59.5%
Cap/Depr(5y)54.84%
Cap/Sales(3y)5.11%
Cap/Sales(5y)4.8%
Profit Quality(3y)96.25%
Profit Quality(5y)104.12%
High Growth Momentum
Growth
EPS 1Y (TTM)1.37%
EPS 3Y0.64%
EPS 5Y2.85%
EPS Q2Q%15.7%
EPS Next Y9.85%
EPS Next 2Y8.02%
EPS Next 3Y7.82%
EPS Next 5Y7.93%
Revenue 1Y (TTM)5.08%
Revenue growth 3Y4.1%
Revenue growth 5Y1.6%
Sales Q2Q%6.77%
Revenue Next Year5.61%
Revenue Next 2Y5.47%
Revenue Next 3Y5.32%
Revenue Next 5Y5.37%
EBIT growth 1Y2.89%
EBIT growth 3Y4.44%
EBIT growth 5Y4.79%
EBIT Next Year30.55%
EBIT Next 3Y13.35%
EBIT Next 5Y8.85%
FCF growth 1Y24.53%
FCF growth 3Y0.14%
FCF growth 5Y-0.08%
OCF growth 1Y19.36%
OCF growth 3Y1.2%
OCF growth 5Y0.72%

JOHNSON & JOHNSON / 1JNJ.MI FAQ

What is the fundamental rating for 1JNJ stock?

ChartMill assigns a fundamental rating of 6 / 10 to 1JNJ.MI.


What is the valuation status of JOHNSON & JOHNSON (1JNJ.MI) stock?

ChartMill assigns a valuation rating of 4 / 10 to JOHNSON & JOHNSON (1JNJ.MI). This can be considered as Fairly Valued.


Can you provide the profitability details for JOHNSON & JOHNSON?

JOHNSON & JOHNSON (1JNJ.MI) has a profitability rating of 7 / 10.


What is the valuation of JOHNSON & JOHNSON based on its PE and PB ratios?

The Price/Earnings (PE) ratio for JOHNSON & JOHNSON (1JNJ.MI) is 19.76 and the Price/Book (PB) ratio is 6.24.


What is the financial health of JOHNSON & JOHNSON (1JNJ.MI) stock?

The financial health rating of JOHNSON & JOHNSON (1JNJ.MI) is 6 / 10.